Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basma Sadaka

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Surgical Clinics of North America|November 12, 2013
Management of antibody-mediated rejection in transplantationBasma Sadaka, Rita R Alloway, E Steve Woodle
Expert Opinion on Investigational Drugs|September 16, 2011
Clinical and investigational use of proteasome inhibitors for transplant rejectionBasma Sadaka, Rita R Alloway, E Steve Woodle
Transplantation|July 27, 2011
A multicenter experience with generic tacrolimus conversionLisa M McDevitt-Potter, Basma Sadaka, Eric M Tichy, et al.
Seminars in Hematology|June 26, 2012
Proteasome inhibition for antibody-mediated allograft rejectionBasma Sadaka, Rita R Alloway, Adele R Shields, et al.
Transplantation|July 28, 2012
Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipientsNicole Schmidt, Rita R Alloway, R Carlin Walsh, et al.
Transplantation|March 25, 2015
A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection TherapyBasma Sadaka, Nicole S Ejaz, Adele R Shields, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Surgical Clinics of North America|November 12, 2013
Management of antibody-mediated rejection in transplantationBasma Sadaka, Rita R Alloway, E Steve Woodle
Expert Opinion on Investigational Drugs|September 16, 2011
Clinical and investigational use of proteasome inhibitors for transplant rejectionBasma Sadaka, Rita R Alloway, E Steve Woodle
Transplantation|July 27, 2011
A multicenter experience with generic tacrolimus conversionLisa M McDevitt-Potter, Basma Sadaka, Eric M Tichy, et al.
Seminars in Hematology|June 26, 2012
Proteasome inhibition for antibody-mediated allograft rejectionBasma Sadaka, Rita R Alloway, Adele R Shields, et al.
Transplantation|July 28, 2012
Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipientsNicole Schmidt, Rita R Alloway, R Carlin Walsh, et al.
Transplantation|March 25, 2015
A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection TherapyBasma Sadaka, Nicole S Ejaz, Adele R Shields, et al.
Pageof 1